MONTREAL (CANADA) AUGUST 22, 2019 – Inversago Pharma today announces that François Ravenelle, Founder and CEO, has been invited to share the company’s most recent results in a presentation entitled:
Inversago Pharma’s CEO François Ravenelle will attend Biotech Showcase to be held January 7-9, 2019 in San Francisco, CA. Come and meet with us!
MONTREAL (CANADA) – 25 July 2018 – Today Inversago Pharma Inc. (“Inversago”) announced that it has secured a $7 million series A financing to pursue its development plan and advance its CB1 platform as a potent treatment for targeted diseases.
Inversago Pharma’s CEO François Ravenelle will attend Biotech Showcase, January 8-10th, 2018 in San Francisco, CA.